China Resources Boya Bio pharmaceutical Group Co Ltd Capital Reinvestment Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd capital reinvestment ratio. China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Capital Reinvestment Ratio of 3.33x as of December 2025, meaning it reinvests 3% of its operating cash flow (CN¥36.82 Million) in capital expenditures (CN¥122.46 Million). Check cash flow reinvestment rate of China Resources Boya Bio pharmaceutical to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Capital reinvestment ratio of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. This chart tracks China Resources Boya Bio pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Also explore 300294 net assets growth trend to track the company's year-over-year net asset growth rate.
China Resources Boya Bio pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
China Resources Boya Bio pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of China Resources Boya Bio pharmaceutical .
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.59x | CN¥116.69 Million | CN¥535.31 Million | ▲ +595.3% |
| 2024 | 0.66x | CN¥299.78 Million | CN¥197.79 Million | ▲ +383.9% |
| 2023 | 0.14x | CN¥641.73 Million | CN¥87.50 Million | ▼ -41.2% |
| 2022 | 0.23x | CN¥596.44 Million | CN¥138.41 Million | ▲ +358.3% |
| 2021 | 0.05x | CN¥1.35 Billion | CN¥68.12 Million | ▼ -74.5% |
| 2020 | 0.20x | CN¥718.58 Million | CN¥142.51 Million | ▼ -93.9% |
| 2018 | 3.26x | CN¥34.90 Million | CN¥113.90 Million | ▲ +116.1% |
| 2016 | 1.51x | CN¥198.76 Million | CN¥300.09 Million | ▲ +39.3% |
| 2015 | 1.08x | CN¥147.02 Million | CN¥159.37 Million | ▲ +175.9% |
| 2014 | 0.39x | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥51.88 Million | CN¥55.40 Million | — |